Skip to main content

ORIGINAL RESEARCH article

Front. Cell. Neurosci., 27 March 2020
Sec. Cellular Neuropathology
Volume 14 - 2020 | https://doi.org/10.3389/fncel.2020.00062

RETRACTED: Resveratrol Preincubation Enhances the Therapeutic Efficacy of hUC-MSCs by Improving Cell Migration and Modulating Neuroinflammation Mediated by MAPK Signaling in a Mouse Model of Alzheimer’s Disease

Xinxin Wang1† Junwei Wu2† Shanshan Ma3 Ya Xie1 Hongtao Liu3 Minghao Yao3 Yanting Zhang3 Greta Luyuan Yang4 Bo Yang5* Ruixia Guo1* Fangxia Guan3,6*
  • 1Department of Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
  • 2Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
  • 3School of Life Sciences, Zhengzhou University, Zhengzhou, China
  • 4Stuyvesant High School, New York, NY, United States
  • 5Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
  • 6Institute of Stem Cell and Regenerative Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Wang X, Wu J, Ma S, Xie Y, Liu H, Yao M, Zhang Y, Yang GL, Yang B, Guo R and Guan F (2020) Resveratrol Preincubation Enhances the Therapeutic Efficacy of hUC-MSCs by Improving Cell Migration and Modulating Neuroinflammation Mediated by MAPK Signaling in a Mouse Model of Alzheimer’s Disease. Front. Cell. Neurosci. 14:62. doi: 10.3389/fncel.2020.00062

Received: 03 November 2019; Accepted: 02 March 2020;
Published: 27 March 2020; Retracted: 23 July 2021.

Edited by:

Guei-Sheung Liu, University of Tasmania, Australia

Reviewed by:

Kobi Rosenblum, University of Haifa, Israel
Laura Schrader, Tulane University, United States
Download